Calidi Biotherapeutics, Inc. (CLDI) — SEC Filings
Calidi Biotherapeutics, Inc. (CLDI) — 1 SEC filings. Latest: 8-K (Apr 2, 2026). Includes 1 8-K.
View Calidi Biotherapeutics, Inc. on SEC EDGAR
Overview
Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded company with 1 SEC filings tracked on ReadTheFiling.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Calidi Biotherapeutics, Inc. is neutral.
Filing Type Overview
Calidi Biotherapeutics, Inc. (CLDI) has filed 1 8-K with the SEC between Apr 2026.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 2, 2026 | 8-K | 8-K Filing |
Frequently Asked Questions
What are the latest SEC filings for Calidi Biotherapeutics, Inc. (CLDI)?
Calidi Biotherapeutics, Inc. has 1 recent SEC filings from Apr 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CLDI filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Calidi Biotherapeutics, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Calidi Biotherapeutics, Inc. (CLDI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Calidi Biotherapeutics, Inc.?
Financial highlights for Calidi Biotherapeutics, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for CLDI?
Investment thesis data for CLDI will be available once enriched filings are processed.
Who are the key executives at Calidi Biotherapeutics, Inc.?
Executive information for Calidi Biotherapeutics, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Calidi Biotherapeutics, Inc. stock?
Risk factor analysis for Calidi Biotherapeutics, Inc. is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Calidi Biotherapeutics, Inc.?
Forward guidance and predictions for Calidi Biotherapeutics, Inc. are extracted from SEC filings as they are enriched.